|
|
Georgia CTSA Weekly eRoundup February 4, 2022
|
|
|
Georgia CTSA Match – Connect with Experts in Your Field
Looking to connect with experts in your field? Join Georgia CTSA Match that encourages meaningful networking and collaboration! This new platform will enable you to connect and communicate with researchers who have similar interests to help move your research forward. Meet new potential collaborators across the Georgia CTSA, cultivate ideas, and utilize as a catalyst for future collaborations and research opportunities. Discover more and Join Now!
|
|
|
|
SOM I3 Nexus Research Awards
In partnership with the Georgia CTSA, the Emory SOM I3 (Imagine, Innovate, and Impact) Nexus Research Awards will provide seed money to fundamental biological and translational investigators for obtaining sufficient data to ultimately develop external collaborative funding applications, and to investigators who may not otherwise engage in multi- and interdisciplinary research. These awards require interdisciplinary team collaboration.
|
|
|
|
Research Showcase at Georgia CTSA Southeast Regional Conference – March 3-4
Over 150 abstracts have been submitted including over 30 oral presentations for the Southeast Regional Clinical & Translational Science Conference. Join us at Callaway Resort & Gardens for this showcase of cutting-edge research during these unprecedented times. View posters of clinical and translational science advances from researchers across the region including Emory, Florida State, Georgia Tech, Georgia Southern, Georgia State, Medical College of Georgia, Medical University of South Carolina, Mercer, Morehouse School of Medicine, UF, and UGA. Learn more .
|
|
|
|
Funding (* New Opportunities)
|
|
|
NIH Funding Opportunities Specific to COVID-19
This page contains a listing of active and expired funding opportunities specific to Coronavirus Disease 2019 (COVID-19).
|
|
|
|
Emergency Awards: HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorder Targets Within the Understudied Druggable Proteome (R21 Clinical Trial Not Allowed) – Due Dates Vary
Supports early-stage research projects focusing on the identification of new druggable targets for pain, opioid use disorder and/or overdose within the understudied druggable proteome.
|
|
|
|
Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed) – Due Dates Vary
Invites applications from early and mid-career investigators (i.e. postdoctoral fellow/associates – associate professor) who strive to expand their research trajectories through the acquisition of new knowledge and skills in the areas of therapeutic drug, biologic, or device development. The development of novel treatments for pain, addiction, and overdose is a vital component to address the ongoing opioid epidemic.
|
|
|
|
Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed) – Due Dates Vary
Supports a postdoctoral or newly independent Early-Stage Investigator of exceptional creativity who proposes novel, original and insightful research concepts with the potential to produce a major impact, test scientific paradigms, or advance key concepts on broad, important problems in biomedical research related to pain, opioid use disorder and/or overdose. Applications proposing unexpected convergence of disciplines, new scientific directions, or the use of novel methodologies are encouraged.
|
|
|
|
HEAL Initiative: Advancing Health Equity in Pain and Comorbidities (R61/R33 Clinical Trial Required) – LOI Due February 20
Solicits applications to develop, test, and implement novel, culturally-appropriate pain interventions and/or adapt, test and evaluate efficacy and effectiveness of existing pain interventions, in populations that disproportionately experience negative health outcomes. Desired outcomes of these interventions include reduction of pain and pain-related symptoms, and improvement in overall health outcomes, including function and quality of life.
|
|
|
|
Coordinating Center for the Claude D. Pepper Older Americans Independence Centers (OAICs) (U24 Clinical Trial Optional) – Internal Due February 21
The National Institute on Aging seeks applications for the Coordinating Center of the Claude D. Pepper Older Americans Independence Centers program. The CC should be proposed only by institutions with (1) the ability to coordinate multi-site projects as demonstrated by previous HHS funding for a coordinating center of a multi-site research grant, and (2) demonstrated scientific expertise in clinical aging research.
|
|
|
|
Simons Collaboration on the Global Brain (SCGB) Conference Awards – Email Inquiry Due February 22
Accepting applications for funding of courses that focus on training in computational and theoretical neuroscience. Courses and conferences that focus on the fields of systems and computational neuroscience are also encouraged to apply.
|
|
|
|
Yerkes National Primate Research Center Pilot Research Program – Due February 25
Projects will be judged on potential to generate high-impact preliminary data that will result in peer-reviewed research project grants from outside sources and in peer-reviewed publications, and on how well they meet the five major review criteria: significance, approach, innovation, investigator and environment.
|
|
|
|
Emergency Awards: HEAL Initiative-Limited Competition: HEAL Initiative Resource Centers for the Pain Management Effectiveness Research Network (ERN) (U24 Clinical Trial Not Allowed) – LOI Due February 28
Solicits applications to continue support of Resource Center activities funded under RFA-TR-15-002 and RFA-TR-15-004; only applicants funded by RFA-TR-15-002 and RFA-TR-15-004 are eligible to apply for this FOA. Applications to this FOA will support Resource Centers for clinical trials funded through the HEAL Pain Management Effectiveness Research Network initiatives, including those funded under RFA-NS-19-021 and RFA-NS-20-028.
|
|
|
|
HEAL Initiative: Secondary Analysis and Integration of Existing Data Related to Acute and Chronic Pain Development or Management in Humans (R21 Clinical Trials Not Allowed) – LOI Due March 1
Funds meritorious applications that analyze existing data and resources from humans, including large, diverse national research cohorts, to answer specific questions about the development of human acute or chronic pain and its management. This FOA may be used to test hypotheses using existing data.
|
|
|
|
Ewing Marion Kauffman Foundation 2022 Knowledge Challenge – Due March 1
Supports activities that improve understanding of entrepreneurship and generate practical, actionable, and rigorous evidence to inform decision making and change systems. Focus areas: systems and structures to support inclusive prosperity and equitable opportunities and the future of work.
|
|
|
|
Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional) – LOI Due March 5
FOA invites eligible US small business concerns to submit STTR grant applications that propose to develop a product, process or service for commercialization with the aim of improving minority health and/or reducing and ultimately eliminating health disparities in one or more NIH-defined health disparity population groups.
|
|
|
|
Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional) – LOI Due March 5
FOA invites eligible US small business concerns to submit SBIR grant applications that propose to develop a product, process or service for commercialization with the aim of improving minority health and/or reducing and ultimately eliminating health disparities in one or more NIH-defined population groups who experience health disparities.
|
|
|
|
NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed) Program – Internal Due March 15
The goal of this R25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on: research experiences, mentoring activities, curriculum or methods development.
|
|
|
|
Johnson & Johnson QuickFire Challenge: Improving Detection of Neurotoxicity in Immunotherapies – Due March 18
J&J is seeking methods and technologies aiming to optimize patient care for immunotherapies within the hematologic malignancy space by enabling the early detection of neurotoxic events. Of particular interest are technologies aiming to identify clinical manifestations to predict acute toxicities, including movement and neurocognitive disorders.
|
|
|
|
* SOM I3 Nexus Research Awards – Due March 24
In partnership with the Georgia CTSA, the Emory SOM I3 (Imagine, Innovate, and Impact) Nexus Research Awards will provide seed money to fundamental biological and translational investigators for obtaining sufficient data to ultimately develop external collaborative funding applications, and to investigators who may not otherwise engage in multi- and interdisciplinary research. These awards require interdisciplinary team collaboration.
|
|
|
|
Georgia CTSA Biostatistics, Epidemiology and Research Design – Due March 31
Georgia CTSA’s Biostatistics, Epidemiology & Research Design (BERD) program is soliciting proposals to support novel methodological research in biostatistics, epidemiology, or health services research to advance clinical and translational research (CTR). Review criteria include quantitative methodological research to fill gaps in CTR, innovation, feasibility, and plans for dissemination and translation of results.
|
|
|
|
Pediatric Research Alliance Pilots Grants – LOI Due April 15
Children's and Emory offer pilot grants for faculty and centers in the Pediatric Research Alliance. These pilots are designed to stimulate new research projects, build new collaborations, and increase extramural funding for pediatric research. Proposals should be aimed towards generating preliminary data for subsequent extramural grant applications.
|
|
|
|
Georgia CTSA TL1 (T32-like) Training Grant Clinical and Translational Research Training – Predoc Due February 15, Postdoc Due March 15
The Georgia CTSA, the NIH-supported Clinical and Translational Science Award TL1 program)6 is focused on providing innovative didactic and mentored research training to individuals interested in careers that encompass clinical and/or translational research. The TL1 program provides an opportunity to complete the Master of Science in Clinical Research or the Certificate Program in Translational Research. The TL1 program supports predoctoral and postdoctoral trainees (medical and PhD students, resident and fellow physicians, PhD postdocs, and residents). A TL1 Grant Writing Application Workshop was held on December 3. The recorded workshop is on the TL1 webpage and at this link .
|
|
|
|
Emory Underrepresented Researchers in Medicine in the Areas of Vascular Factors, Alzheimer's Disease and Related Disorders – Due March 4
The Research Education Component of the Goizueta ADRC in collaboration with the DOM Diversity, Equity, & Inclusion Council is issuing a special RFA from trainees and junior faculty from backgrounds traditionally underrepresented in medicine, who are interested in developing greater experience in Alzheimer’s disease and related dementia research. Applicants who are interested in exploring the link between vascular factors and AD/ADRD are encouraged to apply.
|
|
|
|
Certificate Program in Translational Research (CPTR) – Apply by April 29
The Certificate Program in Translational Research (CPTR) is a formal 16-credit Emory Laney Graduate School program for trainees who seek to conduct research at the interface between basic and translational science and clinical medicine. The CPTR enhances and transforms translational research training for predoctoral PhD students, postdoctoral fellows (PhD or MD) and junior faculty at Emory University, Morehouse School of Medicine, Georgia Institute of Technology, and the University of Georgia.
|
|
|
|
Georgia CTSA Match
Looking to connect with experts in your field? Join the new Georgia CTSA Match! The Georgia CTSA Match encourages meaningful networking and collaboration! This new platform will enable you to connect and communicate with researchers who have similar interests to help move your research forward. Discover more and Join Now!
|
|
|
|
HPLC Bioanalytical Core
Emory HPLC Bioanalytical Core brings powerful platforms in support of investigators. The Core can identify and quantify monoamine neurotransmitters, amino acids, purine bases, and nucleotides from a variety of biological samples. We also provide tailored HPLC service in a broad range of research projects including neuroscience research, cancer research, drug development and clinical trial studies.
|
|
|
|
Bench2Market Talk – February 16
Join us via Zoom at 1:00 PM – 2:00 PM for The Reimbursement Riddle: How to transform a device into dollars. Learn about establishing a viable business model through reimbursement. Topics will include insurance coverage rules, coding, and payment using the Medicare program as a model.
|
|
|
|
TRANSforming Care with Emerging, Novel Devices – Apply by March 30
Do you have a class II or class III medical device that you’re trying to get to market? Join Harvard Catalyst, Harvard’s Clinical & Translational Science Center, for TRANSforming Care with Emerging, Novel Devices (TRANSCEND), a hybrid course exploring the current climate for medical device development. This course begins in April with a four-week virtual session in preparation for three days of live in-person workshops on May 16-18. TRANSCEND culminates in a pitch competition where participants have the opportunity to earn services, consultation, and educational offerings valued at over $15,000.
|
|
|
|
Translational Science 2022 – Chicago – April 20-22
The Association for Clinical and Translational welcomes trainees, educators, researchers, physician scientists, and other health professionals engaged in clinical and translational science. Georgia CTSA Community Engagement Director, Dr. Tabia Akintobi, will be on a leadership panel on April 21 from 4:00 PM-5:00 PM to discuss the state of community engaged clinical research.
|
|
|
|
NIH Technology Accelerator Challenge for Maternal Health – Due April 22
The National Institute of Biomedical Imaging and Biomedical Engineering is launching the NIH Technology Accelerator Challenge for Maternal Health. Up to $1 million in cash prizes to spur and reward the development of low-cost, point-of-care molecular, cellular, and/or metabolic sensing and diagnostic technologies to guide rapid clinical decision-making, improve patient outcomes, and ultimately prevent maternal morbidity and mortality.
|
|
|
|
Participants Needed for COVID-19 Vaccine and Treatment Studies
All races and ethnicities are needed to participate in COVID-19 trials. Please spread the word to help recruit minorities, especially for vaccine trials.
|
|
|
|
Climate Change and Human Health (C2H2) Through a Translational Science Lens – February 10
Join the CTSA Center for Leading Innovation and Collaboration (CLIC) for a virtual meeting from 11:00 AM – 3:30 PM. This unconventional meeting focuses on bringing together researchers, clinicians, policymakers, public health professionals, healthcare innovators, and opinion leaders to discuss and develop innovative and effective ideas regarding climate change in human health.
|
|
|
|
COVID Force Seminar – February 11
Join us via Zoom at 12:00 PM to learn more about “Cardiac MRI Findings in MIS-C" with Matthew Dove, MD, “Long-term Outcomes in MIS-C” with Joshua Kaltman and “Comparison of MIS-C Related Myocarditis, Classic Viral Myocarditis, and COVID-19 Vaccine Related Myocarditis” with Trisha Patel, MD.
|
|
|
|
Cognitive Empowerment Program Research Symposium – February 11
Join us via Zoom at 9:00 AM – 12:00. Attendees will hear from various researchers and collaborators about the work they have accomplished and what they are planning in conjunction with the CEP members in 2022.
|
|
|
|
K-Club – February 14
Early career investigators, please join us via Zoom at 12:00 PM – 1:00 PM to learn more from NIH Program Director Sergey Radaev, PhD about options, interactions with NIH staff, and tips for submitting a strong application. This is an outstanding opportunity to hear directly from an NIH program officer with a demonstrated commitment to researcher career development. Submit questions by February 8 for Dr. Radaev to address at this special K-Club.
|
|
|
|
Health Services Research Seminar Series – February 23
Join us via Zoom at 2:00 PM to learn more about “90-day Outcomes after Peripheral Artery Disease Interventions” with Assistant Professor Olamide Alabi, MD.
|
|
|
|
AI Technologies to Support Individuals Experiencing Cognitive Decline – February 25
Join us in-person for an interactive workshop! The AI-CARING Institute aims to develop novel artificial intelligence systems to support long term care for individuals experiencing cognitive decline and their care networks. The goal of the workshop is to bring together clinical service providers and computing researchers to identify opportunities for developing technologies that identify changing needs and abilities, promote independence through support for daily activities, and assist in planning and coordination of care.
|
|
|
|
Rare Disease Day at NIH – February 28
Join us via Zoom 10:00 AM – 6:00 PM! The goal of this day is to raise awareness and generate positive action for the rare disease community. This year’s theme for Rare Disease Day is “Sharing Your Colors,” highlighting the various different types of rare diseases in the world!
|
|
|
|
CTSA Visiting Scholar Grand Rounds Lecture – February 28
Join us via Zoom at 12:00 PM to learn more about “Parent and Provider Perspectives on Childhood Vaccine Hesitancy” with Duke Assistant Professor Lavanya Vasudevan, PhD, MPH, CPH. The CTSA Visiting Scholar program consists of the CTSA Grand Rounds lecture and virtual meetings between KL2 Scholars and faculty at the host institution and their KL2 peers.
|
|
|
|
Southeast Regional Clinical & Translational Science Conference – March 3-4
Join us at Callaway Resort and Gardens as we bring together researchers from across the region to present the best new health-related preclinical, clinical, implementation, and population- based research and build collaborative relationships. Keynote Speaker for this year’s conference is Joni L. Rutter, PhD, acting director of the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH). Learn more .
|
|
|
|
8th Annual Health Services Research Day – May 4
Join Georgia CTSA colleagues at Emory University SOM on May 4 for this symposium and networking opportunity where researchers across Georgia will learn about ongoing quality, effectiveness, and value-based research activities. Oral and poster presentations will be selected from submitted abstracts. Submit Abstracts by March 7.
|
|
|
|
Annual Southeastern Pediatric Research Conference – June 3
Join us in-person or virtually for the 11th annual conference. The conference will highlight the scope of pediatric research conducted across the US southeast, with emphasis on research from Emory, Children’s Healthcare of Atlanta, Georgia Tech, and Morehouse School of Medicine. This year’s conference theme is "Development and Disease: Translating Insights from Genes and Environment to Transform Outcomes."
|
|
|
|
|